Hi hottod
as a fellow opt holder, although a little later than you, I have been struggling to get my head around the size of each trial arm. I can't see how the statistical robustness of the data would improve greatly from a 100 patient cohort to the 1000 per arm.
crazy numbers. They were asking for trouble cost wise.
Ann: 2023 Annual Report to shareholders, page-164
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.86 |
Change
-0.310(1.54%) |
Mkt cap ! $2.538B | |||
| Open | High | Low | Value | Volume |
| $20.45 | $20.45 | $19.74 | $4.663M | 234.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 507 | $19.76 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.89 | 765 | 1 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |